These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26029782)

  • 1. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway.
    Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ
    Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
    Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
    Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis.
    Mei W; Peng Z; Lu M; Liu C; Deng Z; Xiao Y; Liu J; He Y; Yuan Q; Yuan X; Tang D; Yang H; Tao L
    Nephrology (Carlton); 2015 Nov; 20(11):832-42. PubMed ID: 25989822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis.
    Yang H; Zhang W; Xie T; Wang X; Ning W
    Braz J Med Biol Res; 2019; 52(11):e8772. PubMed ID: 31664306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
    Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
    Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
    Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy.
    Liao X; Jiang Y; Dai Q; Yu Y; Zhang Y; Hu G; Meng J; Xie Y; Peng Z; Tao L
    Biochem Biophys Res Commun; 2021 Jan; 534():694-701. PubMed ID: 33220928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
    Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function.
    Liu W; Zhou H; Dong H; Xing D; Lu M
    Cell Biochem Biophys; 2023 Dec; 81(4):777-785. PubMed ID: 37735328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells.
    Peng ZZ; Hu GY; Shen H; Wang L; Ning WB; Xie YY; Wang NS; Li BX; Tang YT; Tao LJ
    Nephrology (Carlton); 2009 Sep; 14(6):565-72. PubMed ID: 19712256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
    Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
    Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of fluorofenidone on renal interstitial fibrosis in rats with unilateral ureteral obstruction].
    Tan W; Wang W; Zheng X; Chen J; Yuan X; Zhang F; Wang S; Tao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):511-519. PubMed ID: 29886467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage.
    Liao X; Lv X; Zhang Y; Han Y; Li J; Zeng J; Tang D; Meng J; Yuan X; Peng Z; Tao L; Xie Y
    Oxid Med Cell Longev; 2022; 2022():2453617. PubMed ID: 35355864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puerarin attenuates renal fibrosis by reducing oxidative stress induced-epithelial cell apoptosis via MAPK signal pathways in vivo and in vitro.
    Zhou X; Bai C; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
    Ren Fail; 2017 Nov; 39(1):423-431. PubMed ID: 28335679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy.
    Li BX; Tang YT; Wang W; Xie YY; Wang NS; Yuan QJ; Zhang FF; Peng ZZ; Hu GY; Tao LJ
    Mol Cell Biochem; 2011 Aug; 354(1-2):263-73. PubMed ID: 21594754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.
    Qin J; Peng Z; Yuan Q; Li Q; Peng Y; Wen R; Hu Z; Liu J; Xia X; Deng H; Xiong X; Hu J; Tao L
    Sci Rep; 2019 Mar; 9(1):4407. PubMed ID: 30867431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
    Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
    PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
    Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
    Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renalase Protects against Renal Fibrosis by Inhibiting the Activation of the ERK Signaling Pathways.
    Wu Y; Wang L; Deng D; Zhang Q; Liu W
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.